InMode at Canaccord Genuity Conference: Navigating Market Challenges

InMode Ltd, a global leader in energy-based aesthetic treatments, presented its Q2 2024 performance and strategic outlook at the Canaccord Genuity 45th Annual Growth Conference. Despite a $5 million shortfall in Q2 due to U.S. market headwinds, the company reported record growth in Europe and Asia Pacific, resulting in a more balanced revenue mix of 50% U.S. and 50% outside the U.S. The company launched new products including the CO2 laser and Optimus Max to meet demand for combination treatments and is expanding into wellness platforms, such as a device for erectile dysfunction. InMode also announced management and sales team restructuring, with a focus on creating specialized sales roles for different product lines. The company has spent $400 million on share buybacks in the past year, with a total of $500 million over recent years, and is evaluating capital allocation options including dividends, further buybacks, and potential acquisitions in aesthetic and wellness segments. Tariffs are expected to reduce gross margins by 2-3% annually, with mitigation efforts underway.